GT Biopharma, Inc.
GTBP
$1.14
$0.000.00%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 121.06% | -40.14% | -38.44% | -30.61% | -5.69% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 421.50% | 6.38% | -24.19% | 1,277.78% | -76.92% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 817.20% | 0.00% | 0.00% | -- | -- |
| Total Current Assets | 168.02% | -37.19% | -37.39% | -27.06% | -6.25% |
|
|
|||||
| Total Current Assets | 168.02% | -37.19% | -37.39% | -27.06% | -6.25% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 168.02% | -37.19% | -37.39% | -27.06% | -6.51% |
|
|
|||||
| Total Accounts Payable | -42.27% | -38.23% | 47.51% | 52.13% | -46.56% |
| Total Accrued Expenses | -46.29% | -37.01% | -3.80% | 5.84% | 83.28% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 157.94% | -50.00% | 38.46% | -34.30% | -29.70% |
| Total Other Current Liabilities | 157.94% | -50.00% | 38.46% | -34.30% | -29.70% |
| Total Current Liabilities | -36.59% | -38.36% | 26.60% | 24.02% | -18.28% |
|
|
|||||
| Total Current Liabilities | -36.59% | -38.36% | 26.60% | 24.02% | -18.28% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -36.59% | -38.36% | 26.60% | 24.02% | -18.28% |
|
|
|||||
| Common Stock & APIC | 0.77% | 0.21% | 0.00% | 0.00% | 0.57% |
| Retained Earnings | -0.22% | -0.11% | -0.55% | -0.50% | -0.54% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 391.54% | 41.29% | -179.72% | -61.94% | 3.69% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 195,600.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 195,600.00% | 0.00% | 0.00% | 0.00% | 0.00% |
|
|
|||||
| Total Common Equity | 391.54% | 41.29% | -179.72% | -61.94% | 3.69% |
| Total Preferred Equity | 195,600.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 591.53% | 41.32% | -179.64% | -61.93% | 3.69% |
|
|
|||||